RNAZ
Price
$0.53
Change
-$0.01 (-1.85%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
376.6K
TNXP
Price
$17.33
Change
-$0.12 (-0.69%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
114.99M
40 days until earnings call
Ad is loading...

RNAZ vs TNXP

Header iconRNAZ vs TNXP Comparison
Open Charts RNAZ vs TNXPBanner chart's image
TransCode Therapeutics
Price$0.53
Change-$0.01 (-1.85%)
Volume$18.66K
Capitalization376.6K
Tonix Pharmaceuticals Holding
Price$17.33
Change-$0.12 (-0.69%)
Volume$9.33K
Capitalization114.99M
RNAZ vs TNXP Comparison Chart
Loading...
RNAZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RNAZ vs. TNXP commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNAZ is a Hold and TNXP is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (RNAZ: $0.54 vs. TNXP: $17.45)
Brand notoriety: RNAZ and TNXP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RNAZ: 79% vs. TNXP: 63%
Market capitalization -- RNAZ: $376.6K vs. TNXP: $114.99M
RNAZ [@Biotechnology] is valued at $376.6K. TNXP’s [@Biotechnology] market capitalization is $114.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RNAZ’s FA Score shows that 1 FA rating(s) are green whileTNXP’s FA Score has 1 green FA rating(s).

  • RNAZ’s FA Score: 1 green, 4 red.
  • TNXP’s FA Score: 1 green, 4 red.
According to our system of comparison, TNXP is a better buy in the long-term than RNAZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RNAZ’s TA Score shows that 4 TA indicator(s) are bullish while TNXP’s TA Score has 5 bullish TA indicator(s).

  • RNAZ’s TA Score: 4 bullish, 4 bearish.
  • TNXP’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both RNAZ and TNXP are a good buy in the short-term.

Price Growth

RNAZ (@Biotechnology) experienced а -21.97% price change this week, while TNXP (@Biotechnology) price change was -41.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.91%. For the same industry, the average monthly price growth was -7.11%, and the average quarterly price growth was -11.65%.

Reported Earning Dates

RNAZ is expected to report earnings on May 23, 2023.

TNXP is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-4.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TNXP($115M) has a higher market cap than RNAZ($377K). TNXP YTD gains are higher at: -47.089 vs. RNAZ (-83.950). RNAZ has higher annual earnings (EBITDA): -14.33M vs. TNXP (-76.74M). TNXP has more cash in the bank: 55M vs. RNAZ (1.88M). RNAZ has less debt than TNXP: RNAZ (152K) vs TNXP (8.69M). TNXP has higher revenues than RNAZ: TNXP (11.3M) vs RNAZ (0).
RNAZTNXPRNAZ / TNXP
Capitalization377K115M0%
EBITDA-14.33M-76.74M19%
Gain YTD-83.950-47.089178%
P/E Ratio0.00N/A-
Revenue011.3M-
Total Cash1.88M55M3%
Total Debt152K8.69M2%
FUNDAMENTALS RATINGS
TNXP: Fundamental Ratings
TNXP
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RNAZTNXP
RSI
ODDS (%)
Bullish Trend 7 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 10 days ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
RNAZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ABWCX14.74N/A
N/A
AB All Market Total Return C
LVORX16.47N/A
N/A
Lord Abbett Value Opportunities R3
FGRAX43.90N/A
N/A
Franklin Growth Opportunities A
RGAVX13.37N/A
N/A
ClearBridge Global Infrastructure Inc A
BBKCF0.07N/A
-2.08%
BIGG Digital Assets Inc.

RNAZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNAZ has been loosely correlated with NGNE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RNAZ jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAZ
1D Price
Change %
RNAZ100%
+9.27%
NGNE - RNAZ
48%
Loosely correlated
-17.55%
ABCZF - RNAZ
37%
Loosely correlated
N/A
BPTSY - RNAZ
33%
Poorly correlated
N/A
AGEN - RNAZ
32%
Poorly correlated
+6.31%
EDSA - RNAZ
31%
Poorly correlated
-4.92%
More

TNXP and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNXP has been closely correlated with ICU. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if TNXP jumps, then ICU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNXP
1D Price
Change %
TNXP100%
-2.38%
ICU - TNXP
77%
Closely correlated
-9.64%
NEVPF - TNXP
36%
Loosely correlated
N/A
TOVX - TNXP
35%
Loosely correlated
+1.82%
CRVS - TNXP
32%
Poorly correlated
-0.31%
RNAZ - TNXP
28%
Poorly correlated
+9.27%
More